Literature DB >> 8847446

The norepinephrine tissue concentration and neuropeptide Y immunoreactivity in genitourinary organs of the spontaneously hypertensive rat.

Y C Tong1, Y C Hung, S N Lin, J T Cheng.   

Abstract

Tissue concentration of norepinephrine and neuropeptide-Y immunoreactivity (NPY-IR) were measured in the urinary bladder, urethra, prostate and corpus cavernosum of the spontaneously hypertensive rat, as well as the normotensive Wistar-Kyoto rat. The results showed significantly increased tissue norepinephrine concentrations in the urinary bladder, urethra and prostate of the spontaneously hypertensive rat when compared to those of the normotensive rat (hypertensive, n = 18: 18.3 +/- 2.1, 14.9 +/- 1.7, 22.6 +/- 2.3 vs. normotensive, n = 18: 11.2 +/- 1.9, 10.4 +/- 1.3, 16.7 +/- 2.4 nmol/g tissue, respectively, P < 0.05 in each case). No difference was noted in the cavernosal tissue (hypertensive, n = 18: 11.3 +/- 1.6 vs. normotensive, n = 18: 10.1 +/- 1.8 nmol/g tissue, P > 0.01). Correspondingly, tissue NPY-IR was significantly increased in the bladder, urethra and prostate tissue of the spontaneously hypertensive rat (hypertensive, n = 18: 39.7 +/- 5.6, 25.3 +/- 3.4, 31.5 +/- 2.8 vs. normotensive, n = 18: 27.4 +/- 3.1, 18.6 +/- 2.7, 24.2 +/- 3.2 pmol/g tissue, respectively, P < 0.05 in each case). Again, no significant difference was observed in the cavernosal tissue (hypertensive, n = 18: 15.9 +/- 2.2 vs. normotensive, n = 18: 14.8 +/- 2.6 pmol/g tissue, P > 0.01). It is therefore concluded that increased tissue concentration of norepinephrine and NPY-IR were present in the urinary bladder, urethra and prostate of the spontaneously hypertensive rat. The significance of such biochemical findings needs further investigation but may suggest increased sympathetic innervation or activity. On the contrary, no corresponding changes were observed in the corpus cavernosum of the hypertensive rat.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8847446     DOI: 10.1016/0165-1838(95)00088-7

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  5 in total

1.  Sexual Function and alpha-Blockers.

Authors:  Kevin T McVary
Journal:  Rev Urol       Date:  2005

Review 2.  Animal models in urological disease and sexual dysfunction.

Authors:  Gordon McMurray; James H Casey; Alasdair M Naylor
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 3.  The relationship between erectile dysfunction and lower urinary tract symptoms: epidemiological, clinical, and basic science evidence.

Authors:  Kevin T McVary; Kevin E McKenna
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 2.862

4.  Progesterone reduces erectile dysfunction in sleep-deprived spontaneously hypertensive rats.

Authors:  Monica L Andersen; Raquel C S Martins; Tathiana A F Alvarenga; Isabela B Antunes; Ligia A Papale; Sergio Tufik
Journal:  Reprod Biol Endocrinol       Date:  2007-03-01       Impact factor: 5.211

5.  Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction.

Authors:  Amel Kardasevic; Snjezana Milicevic
Journal:  Med Arch       Date:  2017-02-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.